CIBC World Markets Annual Healthcare Conference to Webcast OrthoLogic Presentation
04 Noviembre 2005 - 4:28PM
PR Newswire (US)
TEMPE, Ariz., Nov. 4 /PRNewswire-FirstCall/ -- OrthoLogic Corp.
(NASDAQ:OLGC) announced today that management will provide an
overview of the Company and its lead compound for tissue and bone
healing, Chrysalin(R), at the CIBC World Markets Annual Healthcare
Conference. The presentation will be delivered at 2:30 p.m. EST on
Monday, November 7, 2005 from The Waldorf-Astoria Hotel. The
presentation will be webcast live and may be accessed by visiting
the Investors section of the Company's website,
http://www.orthologic.com/. It will be archived for 30 days.
OrthoLogic is a biotechnology company focused on the development
and commercialization of the novel synthetic peptide Chrysalin(R)
(TP508) in three lead indications, all of which represent areas of
significant unmet medical need -- fracture repair, diabetic foot
ulcer healing and cartilage defect repair. Based on the Company's
pioneering scientific research of the natural healing cascade,
OrthoLogic has become the leading company focused on tissue and
bone repair. OrthoLogic is committed to developing a pipeline of
novel peptides and other molecules aimed at helping patients with
equally under-served conditions. The Company maintains exclusive
worldwide rights for Chrysalin. OrthoLogic's corporate headquarters
are in Tempe, Arizona. For more information, please visit the
company's Web site: http://www.orthologic.com/. DATASOURCE:
OrthoLogic Corp. CONTACT: Media, Lauren Tortorete of Biosector 2,
+1-212-845-5609; or Investors, Melanie Friedman of Stern Investor
Relations, +1-212-362-1200, both for OrthoLogic Corp. Web site:
http://www.orthologic.com/
Copyright
Orthologic (MM) (NASDAQ:OLGC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Orthologic (MM) (NASDAQ:OLGC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Orthologic (MM) (NASDAQ): 0 recent articles
Más de Orthologic (MM) Artículos de Noticias